These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 1373976

  • 1. Histological diagnosis of hepatocellular carcinoma.
    Callea F, Fabbretti G, Brisigotti M, Cozzutto C.
    Ital J Gastroenterol; 1992 Jan; 24(1):50-4. PubMed ID: 1373976
    [Abstract] [Full Text] [Related]

  • 2. Natural history of hepatocellular carcinoma as viewed by the pathologist.
    Callea F.
    Appl Pathol; 1988 Jan; 6(2):105-16. PubMed ID: 2839213
    [Abstract] [Full Text] [Related]

  • 3. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P.
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [Abstract] [Full Text] [Related]

  • 4. Pathology of hepatocellular carcinoma.
    Callea F, Favret M, Marino C, Brisigotti M.
    J Surg Oncol Suppl; 1993 Dec; 3():168-9. PubMed ID: 8389164
    [Abstract] [Full Text] [Related]

  • 5. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD, Rege JD, Joshi AS, Vaiphei K, Amarapurkar DN.
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [Abstract] [Full Text] [Related]

  • 6. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J, Petraki K, Kavantzas N, Rapti I, Kountouras D, Hadziyannis S.
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [Abstract] [Full Text] [Related]

  • 7. Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.
    Chen GG, Lai PB, Ho RL, Chan PK, Xu H, Wong J, Lau WY.
    J Med Virol; 2004 Jun; 73(2):187-94. PubMed ID: 15122791
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical study of HBV antigens in 338 liver cell carcinomas.
    Herrmann G.
    Z Gastroenterol; 1999 May; 37(5):329-42. PubMed ID: 10413841
    [Abstract] [Full Text] [Related]

  • 9. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ, Li C, Zhou XJ, Guan HG, Qin L, Li P, Wang ZW, Qian HX.
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [Abstract] [Full Text] [Related]

  • 10. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
    Geramizadeh B, Boub R, Rahsaz M.
    Indian J Pathol Microbiol; 2007 Jul; 50(3):507-10. PubMed ID: 17883119
    [Abstract] [Full Text] [Related]

  • 11. Sarcomatoid hepatocellular carcinoma with hepatoblastoma-like features in an adult.
    Cho MS, Lee SN, Sung SH, Han WS.
    Pathol Int; 2004 Jun; 54(6):446-50. PubMed ID: 15144405
    [Abstract] [Full Text] [Related]

  • 12. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
    Ramalho FS, Ramalho LN, Della Porta L, Zucoloto S.
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
    [Abstract] [Full Text] [Related]

  • 13. [Differential diagnosis of hepatocellular carcinoma using laser DNA-cytofluorometry].
    Pimenova EL, Bogatyrev VN, Sheremet'eva GF, Got'e SV, Kamalov IuR, Chistiakova OV, Ivanova AG.
    Arkh Patol; 2000 Aug; 62(4):11-6. PubMed ID: 10971867
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical demonstration of alpha-fetoprotein in small hepatocellular carcinoma.
    Sato K, Tanaka M, Kusaba T, Fukuda H, Tanikawa K.
    Oncol Rep; 1998 Aug; 5(2):355-8. PubMed ID: 9468556
    [Abstract] [Full Text] [Related]

  • 15. Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma.
    Sakamoto M, Mori T, Masugi Y, Effendi K, Rie I, Du W.
    Intervirology; 2008 Aug; 51 Suppl 1():42-5. PubMed ID: 18544947
    [Abstract] [Full Text] [Related]

  • 16. Alpha-fetoprotein in hepatocellular carcinoma: a serological and histochemical study in Malaysian patients.
    Yap SF, Peh SC.
    Malays J Pathol; 1991 Dec; 13(2):115-8. PubMed ID: 1726642
    [Abstract] [Full Text] [Related]

  • 17. Proliferating cell nuclear antigen (PCNA) activity in hepatocellular carcinoma, benign peri-neoplastic and normal liver.
    Mun KS, Cheah PL, Baharudin NB, Looi LM.
    Malays J Pathol; 2006 Dec; 28(2):73-7. PubMed ID: 18376794
    [Abstract] [Full Text] [Related]

  • 18. Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma.
    Himoto T, Kuriyama S, Zhang JY, Chan EK, Kimura Y, Masaki T, Uchida N, Nishioka M, Tan EM.
    Int J Oncol; 2005 Oct; 27(4):1079-85. PubMed ID: 16142326
    [Abstract] [Full Text] [Related]

  • 19. Integrins as differential cell lineage markers of primary liver tumors.
    Volpes R, van den Oord JJ, Desmet VJ.
    Am J Pathol; 1993 May; 142(5):1483-92. PubMed ID: 7684197
    [Abstract] [Full Text] [Related]

  • 20. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM, Larson AM, Campbell JS, Fausto N, Rulyak SJ, Swanson PE.
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.